接受乳腺癌根治术后放疗的患者行胸肌前与胸肌后乳房重建的并发症比较:一项系统评价和荟萃分析。
Complications After Prepectoral Versus Subpectoral Breast Reconstruction in Patients Receiving Postmastectomy Radiation Therapy: A Systematic Review and Meta-Analysis.
机构信息
Department of Dermatology and Aesthetic Medicine, Beijing Chao-Yang Hospital, Capital Medical University, 5 Jingyuan Road, Beijing, China.
出版信息
Aesthetic Plast Surg. 2024 Nov;48(21):4421-4429. doi: 10.1007/s00266-024-04096-w. Epub 2024 May 3.
BACKGROUND
Outcomes of immediate breast reconstructions can be influenced by postoperative radiotherapy. However, there is no clarity on the use of prepectoral or subpectoral breast reconstruction in the setting of postmastectomy radiation therapy (PMRT). We reviewed evidence on the complication rates of prepectoral and subpectoral breast reconstruction in women undergoing PMRT.
METHODS
PubMed, Web of Science, and Embase databases were scanned for studies comparing complication rates of prepectoral and subpectoral breast reconstruction with PMRT. All complications were pooled in a random-effect meta-analysis to obtain odds ratio (OR).
RESULTS
Eight observational studies were included. Meta-analysis showed no difference in the risk of infections (OR: 1.22 95% CI 0.79, 1.88 I=0%), implant loss (OR: 0.86 95% CI 0.50, 1.50 I=14%), seroma (OR: 1.01 95% CI 0.43, 2.34 I=50%), hematoma (OR: 0.44 95% CI 0.12, 1.71 I=0%), wound dehiscence (OR: 0.95 95% CI 0.42, 2.17 I=0%), and skin necrosis (OR: 0.61 95% CI 0.21, 1.75 I=36%), contracture (OR: 0.46 95% CI 0.15, 1.48 I=54%) and the need for revision surgeries (OR: 0.85 95% CI 0.45, 1.60 I=15%) between the prepectoral and subpectoral groups.
CONCLUSIONS
Data from observational studies indicates that in appropriately selected patients there may not be any difference in the risk of early complications with prepectoral or subpectoral breast reconstruction with PMRT. Current evidence is limited by the small number of studies, short follow-up and selection bias. There is a need for randomized controlled trials comparing the two approaches to obtain robust evidence on long-term outcomes.
LEVEL OF EVIDENCE III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266 .
背景
即刻乳房重建的结果可能受到术后放疗的影响。然而,在乳房切除术后放疗(PMRT)的情况下,对于胸肌前或胸肌下乳房重建的应用尚不清楚。我们回顾了关于接受 PMRT 的女性中胸肌前和胸肌下乳房重建的并发症发生率的证据。
方法
扫描 PubMed、Web of Science 和 Embase 数据库以比较胸肌前和胸肌下乳房重建与 PMRT 的并发症发生率的研究。所有并发症均在随机效应荟萃分析中汇总,以获得优势比(OR)。
结果
纳入了 8 项观察性研究。荟萃分析显示,感染风险(OR:1.22,95%CI 0.79,1.88,I=0%)、植入物丢失(OR:0.86,95%CI 0.50,1.50,I=14%)、血清肿(OR:1.01,95%CI 0.43,2.34,I=50%)、血肿(OR:0.44,95%CI 0.12,1.71,I=0%)、伤口裂开(OR:0.95,95%CI 0.42,2.17,I=0%)和皮肤坏死(OR:0.61,95%CI 0.21,1.75,I=36%)、挛缩(OR:0.46,95%CI 0.15,1.48,I=54%)和需要修复手术(OR:0.85,95%CI 0.45,1.60,I=15%)的风险在胸肌前和胸肌下组之间没有差异。
结论
来自观察性研究的数据表明,在适当选择的患者中,PMRT 时采用胸肌前或胸肌下乳房重建的早期并发症风险可能没有差异。目前的证据受到研究数量少、随访时间短和选择偏倚的限制。需要进行随机对照试验来比较这两种方法,以获得关于长期结果的可靠证据。
证据水平 III:本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南 www.springer.com/00266 。